|
1
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Montagut C and Settleman J: Targeting the
RAF-MEK-ERK pathway in cancer therapy. Cancer Lett. 283:125–134.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davies H, Bignell GR, Cox C, et al:
Mutations of the BRAF gene in human cancer. Nature. 417:949–954.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanekura T, Miyauchi T, Tashiro M and
Muramatsu T: Basigin, a new member of the immunoglobulin
superfamily: Genes in different mammalian species, glycosylation
changes in the molecule from adult organs and possible variation in
the N-terminal sequences. Cell Struct Funct. 16:23–30. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyauchi T, Kanekura T, Yamaoka A, Ozawa
M, Miyazawa S and Muramatsu T: Basigin, a new, broadly distributed
member of the immunoglobulin superfamily, has strong homology with
both the immunoglobulin V domain and the beta-chain of major
histocompatibility complex class II antigen. J Biochem.
107:316–323. 1990.PubMed/NCBI
|
|
7
|
Muramatsu T: Basigin: A multifunctional
membrane protein with an emerging role in infections by malaria
parasites. Expert Opin Ther Targets. 16:999–1011. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bordador LC, Li X, Toole B, Chen B, Regezi
J, Zardi L, Hu Y and Ramos DM: Expression of emmprin by oral
squamous cell carcinoma. Int J Cancer. 85:347–352. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ishibashi Y, Matsumoto T, Niwa M, Suzuki
Y, Omura N, Hanyu N, Nakada K, Yanaga K, Yamada K, Ohkawa K, et al:
CD147 and matrix metalloproteinase-2 protein expression as
significant prognostic factors in esophageal squamous cell
carcinoma. Cancer. 101:1994–2000. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Muraoka K, Nabeshima K, Murayama T, Biswas
C and Koono M: Enhanced expression of a tumor-cell-derived
collagenase-stimulatory factor in urothelial carcinoma: Its
usefulness as a tumor marker for bladder cancers. Int J Cancer.
55:19–26. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nabeshima K, Suzumiya J, Nagano M, Ohshima
K, Toole BP, Tamura K, Iwasaki H and Kikuchi M: Emmprin, a cell
surface inducer of matrix metalloproteinases (MMPs), is expressed
in T-cell lymphomas. J Pathol. 202:341–351. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Polette M, Gilles C, Marchand V, Lorenzato
M, Toole B, Tournier JM, Zucker S and Birembaut P: Tumor
collagenase stimulatory factor (TCSF) expression and localization
in human lung and breast cancers. J Histochem Cytochem. 45:703–709.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sameshima T, Nabeshima K, Toole BP,
Yokogami K, Okada Y, Goya T, Koono M and Wakisaka S: Glioma cell
extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147)
stimulates production of membrane-type matrix metalloproteinases
and activated gelatinase A in co-cultures with brain-derived
fibroblasts. Cancer Lett. 157:177–184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Lin J, Kanekura T, Su J, Lin W,
Xie H, Wu Y, Li J, Chen M and Chang J: A small interfering
CD147-targeting RNA inhibited the proliferation, invasiveness, and
metastatic activity of malignant melanoma. Cancer Res.
66:11323–11330. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanekura T, Chen X and Kanzaki T: Basigin
(CD147) is expressed on melanoma cells and induces tumor cell
invasion by stimulating production of matrix metalloproteinases by
fibroblasts. Int J Cancer. 99:520–528. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanekura T and Chen X: CD147/basigin
promotes progression of malignant melanoma and other cancers. J
Dermatol Sci. 57:149–154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su J, Chen X and Kanekura T: A
CD147-targeting siRNA inhibits the proliferation, invasiveness, and
VEGF production of human malignant melanoma cells by
down-regulating glycolysis. Cancer Lett. 273:140–147. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marieb EA, Zoltan-Jones A, Li R, Misra S,
Ghatak S, Cao J, Zucker S and Toole BP: Emmprin promotes
anchorage-independent growth in human mammary carcinoma cells by
stimulating hyaluronan production. Cancer Res. 64:1229–1232. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang JM, O'Neill P, Jin W, Foty R, Medina
DJ, Xu Z, Lomas M, Arndt GM, Tang Y, Nakada M, et al: Extracellular
matrix metalloproteinase inducer (CD147) confers resistance of
breast cancer cells to Anoikis through inhibition of Bim. J Biol
Chem. 281:9719–9727. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eskandarpour M, Kiaii S, Zhu C, Castro J,
Sakko AJ and Hansson J: Suppression of oncogenic NRAS by RNA
interference induces apoptosis of human melanoma cells. Int J
Cancer. 115:65–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie W, Xie H, Liu F, Li W, Dan J, Mei Y,
Dan L, Xiao X, Li J and Chen X: Propranolol induces apoptosis of
human umbilical vein endothelial cells through downregulation of
CD147. Br J Dermatol. 168:739–748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sala E, Mologni L, Truffa S, Gaetano C,
Bollag GE and Gambacorti-Passerini C: BRAF silencing by short
hairpin RNA or chemical blockade by PLX4032 leads to different
responses in melanoma and thyroid carcinoma cells. Mol Cancer Res.
6:751–759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chapman PB, Hauschild A, Robert C, Haanen
JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et
al: BRIM-3 Study Group: Improved survival with vemurafenib in
melanoma with BRAF V600E mutation. N Engl J Med. 364:2507–2516.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang R, He G, Nelman-Gonzalez M, Ashorn
CL, Gallick GE, Stukenberg PT, Kirschner MW and Kuang J: Regulation
of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell.
128:1119–1132. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Z, Wang M, Lazo JS and Carr BI:
Identification of epidermal growth factor receptor as a target of
Cdc25A protein phosphatase. J Biol Chem. 277:19470–19475. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prahallad A, Sun C, Huang S, Di
Nicolantonio F, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A
and Bernards R: Unresponsiveness of colon cancer to BRAF (V600E)
inhibition through feedback activation of EGFR. Nature.
483:100–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
